| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.07 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.07 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.07 |